| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/16/2001 | WO2001058957A2 Enhancing the circulating half-life of antibody-based fusion proteins |
| 08/16/2001 | WO2001058955A1 Targeted destruction of pests |
| 08/16/2001 | WO2001058950A1 Improved interleukin 10 |
| 08/16/2001 | WO2001058940A2 Adenoviral capsid containing chimeric protein ix |
| 08/16/2001 | WO2001058936A2 Constructs for delivery of therapeutic agents to neuronal cells |
| 08/16/2001 | WO2001058935A2 FACTOR VII OR VIIa-LIKE MOLECULES |
| 08/16/2001 | WO2001058910A2 Lipid-based drug delivery systems |
| 08/16/2001 | WO2001058493A1 Conjugates of follicle stimulating hormones |
| 08/16/2001 | WO2001058478A1 Antigenic complexes and methods |
| 08/16/2001 | WO2001058474A2 Microencapsulation and sustained release of biologically active agent |
| 08/16/2001 | WO2001058472A2 Botulinum toxin pharmaceutical compositions |
| 08/16/2001 | WO2001058470A2 Methods for enhancing the bioavailability of a drug |
| 08/16/2001 | WO2001058466A1 Biodegradable and biocompatible polymeric microspheres encapsulating salmonella enteritidisbacteria |
| 08/16/2001 | WO2001058455A1 Method to potentiate the therapeutic efficacy of taxane and derivatives thereof |
| 08/16/2001 | WO2001058451A1 Tamper-resistant oral opioid agonist formulations |
| 08/16/2001 | WO2001058447A1 Controlled-release compositions containing opioid agonist and antagonist |
| 08/16/2001 | WO2001058433A1 Timed pulsatile drug delivery systems |
| 08/16/2001 | WO2001058429A1 Acrylic enteric coating compositions |
| 08/16/2001 | WO2001058426A1 Sustained release composition comprising insuline like growth factor |
| 08/16/2001 | WO2001058266A1 Therapeutic platelets and methods |
| 08/16/2001 | WO2001058240A2 Photodynamic therapy for treating conditions of the eye |
| 08/16/2001 | WO2001058238A2 Method and system for producing customized cosmetic and pharmaceutical formulations on demand |
| 08/16/2001 | WO2001024773B1 Liposome-entrapped dna oral vaccines |
| 08/16/2001 | WO2001010415B1 A binder for pharmaceutical compositions |
| 08/16/2001 | WO2001010413A3 Periodic structures comprising lipids, polyelectrolytes, and structures-inducing soluble oligovalent linkers |
| 08/16/2001 | WO2000076551A3 Method for producing an injectable medicament preparation |
| 08/16/2001 | WO2000069473A3 Macromolecular carrier for drug and diagnostic agent delivery |
| 08/16/2001 | WO2000057866A3 Use of azalide antibiotics for the topical treatment or prevention of ocular infections |
| 08/16/2001 | WO2000050077A9 Immunogens comprising a peptide and a carrier derived from h.influenzae protein d |
| 08/16/2001 | US20010014685 Injectable pharmaceutical composition for treatment and reversal of erectile dysfunction |
| 08/16/2001 | US20010014475 Aggregate suitable for implantation comprising an aggregate of cells and biodegradable microcarrier particles; cell microcarrier aggregates are grown in mold shaped to conform to the geometry of the desired body part |
| 08/16/2001 | US20010014354 Stability |
| 08/16/2001 | US20010014349 Consists of a local anesthetics and the antipruritic agent such as lidocaine and an alcohol (c1-c4) or acetone which is water miscible, and solubilizes the anesthetic and is volatile and devoid any compound other than water |
| 08/16/2001 | US20010014346 Controlling acarid, lepidopteran, fungal and bacterial pest infestations in colonies of honeybees by applying an effective amount of an essential oil or an organic acid in slow-release formulaton to the locus of honeybee colonies |
| 08/16/2001 | US20010014340 A tablet comprising; sugar alcohol or saccaride selected from mannitol and lactose, each having an average particle diameter of not more than 30 mu m, an active ingredient, and crosscarmellose sodium, crosspovidone etc. as disintegrant |
| 08/16/2001 | US20010014334 Methods and materials for the treatment of prostatic carcinoma |
| 08/16/2001 | EP1123700A1 Timed pulsatile drug delivery systems |
| 08/16/2001 | EP1123396A2 Minimal promoters and uses thereof |
| 08/16/2001 | EP1123313A2 Methods and compositions for the prevention and treatment of anemia |
| 08/16/2001 | EP1123301A1 Chelating agents for radioimmunotherapy |
| 08/16/2001 | EP1123283A1 Thiazole-derivatives |
| 08/16/2001 | EP1123129A1 Systems and compounds for drug delivery to interstitial regions of the myocardium |
| 08/16/2001 | EP1123120A1 Medicinal aerosol formulation |
| 08/16/2001 | EP1123115A1 Treatment of trauma (ie graft rejection) with liposomes containing dna encoding for ctla4ig or for anti cd40l |
| 08/16/2001 | EP1123114A1 Virus-like particles for the induction of autoantibodies |
| 08/16/2001 | EP1123113A1 Ribozymes used as prodrugs |
| 08/16/2001 | EP1123112A1 Ionic molecular conjugates of n-acylated derivatives of poly (2-amino-2-deoxy-d-glucose) and polypeptides |
| 08/16/2001 | EP1123104A1 Inherently antimicrobial quaternary amine hydrogel wound dressings |
| 08/16/2001 | EP1123103A1 A process for producing an iron-dextran compound |
| 08/16/2001 | EP1123101A1 Fluticasone lotion having improved vasoconstrictor activity |
| 08/16/2001 | EP1123089A1 Tablet for crunching with masked taste and instant release of active principle and method for making same |
| 08/16/2001 | EP1123088A1 Controlled-release pharmaceutical formulations containing a cgmp pde-5 inhibitor |
| 08/16/2001 | EP1123087A1 Oral pulsed dose drug delivery system |
| 08/16/2001 | EP1123086A2 Artificial antigen-specific cells and related methods |
| 08/16/2001 | EP1123085A1 O/w emulsion comprising an hydroxylated oil |
| 08/16/2001 | EP1123082A1 Preparations for topical application of substances having antiandrogenic effect |
| 08/16/2001 | EP1123008A2 Preparation and use of solidified oils |
| 08/16/2001 | EP1037597B1 Use of hyperbranched polymers and dendrimers comprising a particular group as film-forming agent, film-forming compositions comprising same and use particularly in cosmetics and pharmaceutics |
| 08/16/2001 | EP0852488B1 Topical composition containing a silicone-grafted polymer and an amine silicone and/or a silicone gum or resin |
| 08/16/2001 | EP0837698B1 Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates |
| 08/16/2001 | EP0768876B1 Stable oil-in-water emulsions incorporating a taxine (taxol) and method of making same |
| 08/16/2001 | EP0725634B1 Plaster for the treatment of nail mycoses |
| 08/16/2001 | EP0706380B1 Encapsulated medicine |
| 08/16/2001 | EP0702958B1 Vaginal preparation containing physiologically active peptide |
| 08/16/2001 | EP0587639B1 Pharmaceutical compositions |
| 08/16/2001 | DE10005942A1 Production of graft copolymers used e.g. as coatings by polymerizing vinyl esters in presence of solid polyether comprises using liquid polyalkylene glycol as solvent for radical initiator |
| 08/16/2001 | CA2714081A1 Methods and compositions for treating conditions of the eye |
| 08/16/2001 | CA2400186A1 Microencapsulation and sustained release of biologically active agent |
| 08/16/2001 | CA2399821A1 Lipid-based drug delivery systems containing phospholipase a2 degradable lipid derivatives and the therapeutic uses thereof |
| 08/16/2001 | CA2399450A1 Gels of hyaluronic acid cross-linked with bi-functional l-aminoacids or l-aminoesters or mixtures thereof |
| 08/16/2001 | CA2398840A1 Method to potentiate the therapeutic efficacy of taxane and derivatives thereof |
| 08/16/2001 | CA2398679A1 Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 08/16/2001 | CA2398567A1 Methods for enhancing the bioavailability of a drug |
| 08/16/2001 | CA2398296A1 Method for loading a red blood cell with an agent |
| 08/16/2001 | CA2397362A1 Therapeutic platelets and methods |
| 08/16/2001 | CA2366522A1 Non-naturally occurring nucleic acid compositions, their use for the preparation of formulations useful for transfecting a nucleic acid into cells and applications |
| 08/16/2001 | CA2366458A1 Method and system for producing customized cosmetic and pharmaceutical formulations on demand |
| 08/15/2001 | CN1308674A Multivalent T cell receptor complexes |
| 08/15/2001 | CN1308639A Linear cyclodextrin copolymers |
| 08/15/2001 | CN1308637A Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 08/15/2001 | CN1308548A Adhesive microsphere drug delivery composition |
| 08/15/2001 | CN1308547A Novel compositions |
| 08/15/2001 | CN1308539A Process for producing an iron-dextran compound |
| 08/15/2001 | CN1308537A Steroid-containing cataplasms and process for producing the same |
| 08/15/2001 | CN1308530A Use of tricyclic antidepressants for local analgesia |
| 08/15/2001 | CN1308528A Plaster which contains steroids, and method for the production and use thereof |
| 08/15/2001 | CN1308527A Topical plaster with non-steroidal antirheumatic agents with an acid group |
| 08/15/2001 | CN1308526A Composition containing glycerol trinitrate, method for producing said composition and use of the same |
| 08/15/2001 | CN1308525A Transdermal plaster containing at least one active ingredient which infuences blood serum lipid levels |
| 08/15/2001 | CN1308523A Pellets having a core coated with a lipid lowering agent and a polymer |
| 08/15/2001 | CN1308091A Preparation of water soluble or water dispersive polymer containing polyether and its application as medicine ingredient or coating agent and adhesive in packing material |
| 08/15/2001 | CN1308078A Camptothecin derivative and its preparation |
| 08/15/2001 | CN1308054A (3S,4S) and (3R,4R)-beta-methyl-gamma-hydroxy-alkyl nitrile and its preparation and use |
| 08/15/2001 | CN1307906A Medicine targeting carrier |
| 08/15/2001 | CN1307905A Recombinant human interleukin-2 protectant |
| 08/15/2001 | CN1307903A Vaccine wine oil adjuvant |
| 08/15/2001 | CN1307870A Crystallized pirimiphos-methyl composite and its preparation and usage |
| 08/15/2001 | CN1307866A Production process of polymerized micelle with injected medicine and polymerized micelle composite |
| 08/15/2001 | CN1307865A Nanometer emulsion containing amphiphilic lipoid and polyglycol ester |
| 08/15/2001 | CN1069693C Process for purifying alkoxylated fats |